Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
645
+2
+0.3% +$685 0.05% 155
2026
Q1
$226K Buy
643
+1
+0.2% +$356 0.04% 173
2025
Q4
$210K Buy
+642
New +$204K 0.03% 173
2024
Q4
Sell
-6,827
Closed -$2.2M 202
2024
Q3
$2.2M Sell
6,827
-15
-0.2% -$4.91K 0.41% 58
2024
Q2
$2.14M Sell
6,842
-14
-0.2% -$4.11K 0.41% 59
2024
Q1
$1.95M Sell
6,856
-18,786
-73% -$5.5M 0.38% 60
2023
Q4
$7.39M Buy
25,642
+51
+0.2% +$13.9K 1.4% 16
2023
Q3
$6.88M Buy
25,591
+98
+0.4% +$24.5K 1.36% 16
2023
Q2
$5.66M Buy
25,493
+2
+0% +$464 1.08% 23
2023
Q1
$6.16M Buy
25,491
+1
+0% +$245 1.25% 20
2022
Q4
$6.69M Sell
25,490
-161
-0.6% -$43.2K 1.49% 17
2022
Q3
$5.78M Buy
25,651
+258
+1% +$62.5K 1.28% 21
2022
Q2
$6.18M Buy
25,393
+2
+0% +$490 1.29% 22
2022
Q1
$6.14M Sell
25,391
-151
-0.6% -$34.7K 1.07% 28
2021
Q4
$5.75M Buy
25,542
+18,844
+281% +$3.98M 0.82% 35
2021
Q3
$1.42M Buy
+6,698
New +$1.54M 0.31% 86
2019
Q3
Sell
-1,288
Closed -$237K 163
2019
Q2
$237K Sell
1,288
-368
-22% -$65.9K 0.09% 146
2019
Q1
$315K Buy
1,656
+4
+0.2% +$764 0.12% 132
2018
Q4
$322K Sell
1,652
-208
-11% -$40.6K 0.14% 113
2018
Q3
$386K Sell
1,860
-666
-26% -$131K 0.14% 115
2018
Q2
$466K Sell
2,526
-532
-17% -$94.1K 0.19% 99
2018
Q1
$521K Sell
3,058
-53
-2% -$9.73K 0.22% 91
2017
Q4
$541K Sell
3,111
-729
-19% -$129K 0.22% 96
2017
Q3
$716K Buy
3,840
+474
+14% +$84K 0.31% 79
2017
Q2
$580K Buy
3,366
+750
+29% +$122K 0.27% 85
2017
Q1
$429K Buy
+2,616
New +$435K 0.2% 97

Other funds holding AMGN

Strategic Advisors's AMGN Position: Q2 2026 in Review

Strategic Advisors increased its Amgen (AMGN) stake by 0.31% in Q2 2026, buying an estimated $685 and bringing the position to 645 shares worth $234K. The position accounts for 0.05% of the portfolio, ranked #155.

Strategic Advisors first reported a position in AMGN in Q1 2017 and has held it in 26 quarters since. The position peaked at $7.39M in Q4 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Strategic Advisors held 645 shares of Amgen worth $234K as of Q2 2026.
  • Strategic Advisors bought 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.05% of Strategic Advisors's portfolio in Q2 2026, its #155 holding.
  • Strategic Advisors first reported a position in Amgen in Q1 2017 and has held it in 26 quarters since.
  • Strategic Advisors's Amgen position peaked at $7.39M in Q4 2023.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Strategic Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.